Veeva Commercial Summit Connects Nearly 1,500 Life Sciences Leaders Across Sales, Medical, and Marketing

Veeva Systems (NYSE: VEEV) has announced the 2023 Veeva Commercial Summit scheduled for May 2-3 in Boston, featuring industry leaders from Bristol Myers Squibb, Genentech, Janssen, Lilly, and Merck.

Rhea-AI Summary

Veeva Systems (NYSE: VEEV) has announced the 2023 Veeva Commercial Summit scheduled for May 2-3 in Boston, featuring industry leaders from Bristol Myers Squibb, Genentech, Janssen, Lilly, and Merck. This event will host nearly 1,500 professionals and cover over 90 sessions focused on enhancing commercial strategies through digital engagement and data analytics. Veeva's CEO, Peter Gassner, will present the opening keynote, emphasizing the integration of sales, medical, and marketing. The summit aims to share insights on transforming customer engagement in the biopharma sector, featuring keynotes on omnichannel strategies, bridging marketing and medical operations, and patient-level data. The event is open to professionals in the life sciences industry.

Positive

• The summit will host nearly 1,500 professionals, indicating strong industry engagement.
• Keynote speakers from leading biopharma companies emphasize Veeva's influence in the market.
• Focus on digital engagement and analytics showcases Veeva's commitment to innovation in the life sciences sector.

Negative

• None.

Argus Session date unavailable

+2.24% session move Open Argus

Details

News Market Reaction – VEEV

The recorded move for VEEV in the trading session of this news was +2.24%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Bristol Myers Squibb, Genentech, Janssen, Lilly, Merck, and other biopharma leaders to share strategies for advancing commercial excellence

PLEASANTON, Calif., April 18, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from Bristol Myers Squibb, Eli Lilly and Company, Genentech, Janssen, and Merck will be keynote speakers at the 2023 Veeva Commercial Summit on May 2-3 in Boston. Speakers from leading and emerging biopharmas will share how advancements in digital engagement, content, data, and analytics elevate commercial strategy and execution. 

One of the largest industry events in North America for commercial and medical affairs professionals, Veeva Commercial Summit will host nearly 1,500 people across more than 90 sessions. Veeva CEO Peter Gassner will headline the opening keynote with a bold vision to connect sales, medical, and marketing for commercial excellence. Veeva experts will join the stage to showcase the company's plans for future software, data, and services innovations to help companies get the right treatments to patients more efficiently. 

Other featured keynotes include:

• Bristol Myers Squibb on the future of omnichannel and customer engagement.
• Genentech on bridging marketing operations, IT, and medical, legal, and regulatory (MLR) to create meaningful customer experiences.
• Janssen on taking a modern approach to patient-level data that fuels high-impact commercial initiatives.
• Lilly and Merck on advancing medical affairs as a strategic leader at the center of R&D and commercial.

"The industry is transforming engagement with healthcare professionals by creating greater synergies across sales, medical, and marketing," said Paul Shawah, executive vice president at Veeva. "We look forward to bringing the industry together to share effective strategies and insights that advance commercial excellence."

The event is open to life sciences industry professionals. Register and see the full agenda and program details at veeva.com/Summit.

Additional Information
To register for Veeva Commercial Summit, visit: veeva.com/Summit/Register Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com

Contact:

Alison Borris
Veeva Systems
925-226-8821
alison.borris@veeva.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-commercial-summit-connects-nearly-1-500-life-sciences-leaders-across-sales-medical-and-marketing-301799823.html

SOURCE Veeva Systems

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date of the 2023 Veeva Commercial Summit?

The 2023 Veeva Commercial Summit is scheduled for May 2-3, 2023.

Which companies will be represented at the Veeva Commercial Summit?

Keynote speakers will include representatives from Bristol Myers Squibb, Genentech, Janssen, Lilly, and Merck.

Where is the Veeva Commercial Summit taking place?

The Veeva Commercial Summit will be held in Boston, Massachusetts.

How many sessions will be featured at the Veeva Commercial Summit?

The summit will feature over 90 sessions.

What is the focus of the Veeva Commercial Summit?

The summit focuses on advancements in digital engagement, content, data, and analytics for commercial strategy and execution.